okt 18, 2018: 2:45 p.m. - 3:55 p.m.
As new techniques in artificial intelligence expand the functionality of software to find useful results from large data sets, progress companies are already folding such tools into their developments of new therapies to address unmet needs of patients. For example, companies are using the %u201Calways-on%u201D power of computers to filter existing molecular libraries and model new drug discovery techniques in ways never before possible. This session will feature experts working at the intersection of information technology, therapy delivery, and new drug development, who can show the exponential power of machine learning and other artificial intelligence approaches to turn data into medicine.%uFFFD
Moderator: Gini Deshpande, PhD, Founder & Chief Executive Officer, NuMedii%uFFFD